Publication:
EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY

dc.contributor.authorsHatemi, Gulen; Mahr, Alfred; Takeno, Mitsuhiro; Kim, Doyoung; Saadoun, David; Direskeneli, Haner; Cheng, Sue; Mccue, Shannon; Paris, Maria; Chen, Mindy; Yazici, Yusuf
dc.date.accessioned2022-03-12T16:24:28Z
dc.date.accessioned2026-01-11T05:56:59Z
dc.date.available2022-03-12T16:24:28Z
dc.date.issued2019
dc.identifier.doi10.1136/annrheumdis-2019-eular.1651
dc.identifier.eissn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/226354
dc.identifier.wosWOS:000472207100360
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage149
oaire.citation.startPage148
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume78

Files